Johnson & Johnson Innovation Announces Resident Companies now at JLABS @ Toronto

Johnson & Johnson Innovation announced 24 new companies have become residents of Johnson & Johnson Innovation, JLABS @ Toronto since its grand opening exactly a year ago. The 40,000-square-foot life sciences incubator now hosts a total of 40+ companies, and provides these entrepreneurs shared lab space and offices, modular lab suites and access to scientific, industry and capital funding experts. The companies represent a range of sectors including pharmaceuticals, medical devices and consumer health solutions with focus areas such as oncology, vision care, genomics, neuroscience, infectious diseases, immunology and the microbiome.

"Since opening its doors a year ago, JLABS @ Toronto has successfully attracted a multitude of promising companies from our province's life sciences community, led by academic hospitals, world-class research institutes, top scientists and a strong health start-up network," the Honourable Reza Moridi, Minister of Research, Innovation and Science said. "They have helped our province continue to build up Ontario's vibrant innovation ecosystem, create good jobs, and strengthen our position in the global knowledge economy while also providing access to incredible resources for our life science entrepreneurs."

Johnson & Johnson Innovation seeks to fuel the best science and technology to solve unmet medical and healthcare needs. In addition to offering emerging life science companies modular lab units, office space, shared core laboratory equipment, business facilities, third-party services and educational events, JLABS links the entrepreneurs of Toronto with the full breadth of Johnson & Johnson Innovation, including opportunities for funding, access to research and development experts from medical technology, consumer healthcare product and the pharmaceutical teams at Janssen Inc. JLABS @ Toronto provides access to scientific, industry and capital funding experts from across the industry, and operates under the JLABS no-strings attached model, which means resident companies can completely retain their intellectual property and there are no first rights of refusal.

Since opening last year, JLABS @ Toronto has helped boost the Canadian life sciences ecosystem by hosting more than 5,300 attendees at over 50 events. More than 90 experts from a multitude of industries have spoken at these events in the last year. JLABS @ Toronto resident companies are receiving access to expertise from across the Johnson & Johnson Family of Companies.